Drugs Made In America Acquisition Corp
DMAA
32 hedge funds and large institutions have $212M invested in Drugs Made In America Acquisition Corp in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
33% more funds holding
Funds holding: 24 → 32 (+8)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
24% more capital invested
Capital invested by funds: $171M → $212M (+$41M)
3.34% more ownership
Funds ownership: 58.79% → 62.13% (+3.3%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$6.98M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$6.98M |
| 3 |
HCM
Heights Capital Management
San Francisco,
California
|
+$6.57M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$5.76M |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$4.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$17.3M |
| 2 |
QL
Quarry LP
New York
|
-$6.51M |
| 3 |
DAM
DLD Asset Management
New York
|
-$1.63M |
| 4 |
CA
Crossingbridge Advisors
Pleasantville,
New York
|
-$1.3M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$514K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
26
Warberg Asset Management
Winnetka,
Illinois
| $939K | – | – | – |
|
|
BI
27
Bulldog Investors
Saddle Brook,
New Jersey
| $744K | +$738K | +72,964 | New |
|
|
LSC
28
Logan Stone Capital
Chicago,
Illinois
| $622K | +$617K | +60,991 | New |
|
|
VF
29
Virtu Financial
New York
| $476K | +$151K | +14,908 | +47% |
|
30
Geode Capital Management
Boston,
Massachusetts
| $466K | +$1.88K | +186 | +0.4% |
|
31
Morgan Stanley
New York
| $1.11K | +$900 | +89 | +445% |
|
32
UBS Group
Zurich,
Switzerland
| $10 | +$10 | +1 | New |
|
|
CA
33
Crossingbridge Advisors
Pleasantville,
New York
| – | -$1.3M | -850,000 | Closed |
|
|
QL
34
Quarry LP
New York
| – | -$6.51M | -650,000 | Closed |
|
DMAA Hedge Fund Activity: Q2 2025 in Review
32 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition Corp (DMAA) for Q2 2025, worth a combined $212M — up 24% from $171M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DMAA positions and 2 closed out — a net gain of 8 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $6.98M. The largest seller was Toronto Dominion Bank, cutting an estimated $17.3M.
- 32 institutional investors held Drugs Made In America Acquisition Corp (DMAA) as of Q2 2025, up from 24 in Q1 2025.
- Funds reported $212M of Drugs Made In America Acquisition Corp stock for Q2 2025, up 24% quarter-over-quarter.
- 10 funds opened new Drugs Made In America Acquisition Corp positions in Q2 2025 and 2 closed out, a net change of +8 holders.
- The largest Drugs Made In America Acquisition Corp buyer in Q2 2025 was D.E. Shaw & Co, an estimated $6.98M added.
- The largest Drugs Made In America Acquisition Corp seller in Q2 2025 was Toronto Dominion Bank, an estimated $17.3M sold.
Based on aggregated 13F filings for Q2 2025.